SMAD4 and neoplasm: For instance, the loss of Smad4 in tumor epithelial cells mutated in Apc enhances expression of the inflammatory chemokine CCL9 to promote malignant progression of the Apc mutant tumors by recruiting MMP-expressing CCR1+ bone marrow–derived cells as mentioned earlier (5).